Biotech

All Articles

Analysts explore Avidity's DMD gain, revealing nuances in information

.Avidity Biosciences amazed capitalists with stage 1/2 data in Duchenne muscular dystrophy (DMD) Fri...

Actinogen's cortisol blocker falls short period 2 depression research

.Actinogen Medical's cortisol blocker has missed out on the primary endpoint of a stage 2 research i...

Bivictrix makes a decision going private only method to take ADC into medical clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of many a billion-dollar biobuck l...

TPG bests up funds to $580M for investments across lifestyle scientific researches

.Possession supervisor TPG, which has actually sustained biotechs including Sionna Therapeutics and ...

Merck ceases stage 3 TIGIT trial in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT program has gone through one more misfortune. Months after shuttering a peri...

After a difficult year, Exscientia folds up in to Recursion

.After a year described by pipe cuts, the shift of its CEO as well as discharges, Exscientia will co...

Cullinan, after $25M deal, restore bispecific to Port

.Cullinan Rehab was actually thrilled enough with Harbour BioMed's bispecific invulnerable reactor t...

A more detailed look at Strong Biotech's Strong 15

.In this particular full week's incident of "The Top Line," our experts are actually diving right in...

Lilly encounters stage 2 failing of tau-targeting med

.The confetti is still flying coming from Eli Lilly's celebration commemorating the approval of Alzh...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, shooting...